N00bs here

[sdioretthoughts]

Hey everyone!
I'm a mom looking to get back into shape. I'm not new to the fitness world but it definitely feels like the last time I actually participated in it was a lifetime ago. I've been researching some peptides and stumbled into some steroid info, which is pretty interesting. I'm just here to gain some knowledge before I make any decisions.

 

[PiscesMoon]

Hi @sdioretthoughts Welcome to Meso! Thanks for joining in.

 

[BALLISTIC]

Hey everyone!
I'm a mom looking to get back into shape. I'm not new to the fitness world but it definitely feels like the last time I actually participated in it was a lifetime ago. I've been researching some peptides and stumbled into some steroid info, which is pretty interesting. I'm just here to gain some knowledge before I make any decisions.

Welcome if you have any questions ask if you can't find it already spoken about.

My wife isn't on these boards, but she is all the things female enhancement offers. So if I can help, I will. After 3 children, she looks better now then when we met at 14... 40 now.

The other ladies on here are fantastic in their knowledge.

 

[Andrewthatguy]

Reta is a great start.

 

[sdioretthoughts]

Reta is a great start.

Thank you! I'll check this out

 

[Andrewthatguy]

Thank you! I'll check this out

Honestly from just the jist of what you said I’m guessing you want to lose weight, so that’s really all you need. You’ll probably need lower doses too as a lady, but idk I don’t know much about how women react to this stuff.

 

[BALLISTIC]

https://www.nejm.org/doi/full/10.1056/NEJMoa2301972?

This one is the lead. Randomized double blind. Placebo. 48 weeks.

https://www.sciencedirect.com/science/article/pii/S1550413122003126?

Early human study, focusing on safety tolerability, pk/pd. Explains mechanistic.

https://www.thelancet.com/journals/landia/article/PIIS2213-8587%2825%2900092-0/abstract?

Fat mass, lean mass prioritized. 56% female

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial - PMC

Retatrutide is a novel triple agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1 and glucagon receptors. A 48-week phase 2 obesity study demonstrated weight reductions of 22.8% and 24.2% with retatrutide 8 and ...

pmc.ncbi.nlm.nih.gov

Focus on liver fat reduction. Also 8 to 12mg dosing. Pay attention to dosing.a bunch of uneducated fools in these forums are regurgitating false information while studies exist. Not only are they taking irrelevant doses proven by clinical science, they also decided they were smarter and do multiple dosing weekly. Reta requires dosing 1 time weekly, and it's important as you'll see in the studies. It has a purpose.

Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial

Retatrutide, an agonist of glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors, is in development for the tr…

www.sciencedirect.com

Last but not least what the study patients had to say personally.